# The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

> **NCT07093346** · NA · RECRUITING · sponsor: **University of Nottingham** · enrollment: 45 (estimated)

## Conditions studied

- Nonalcoholic Fatty Liver Disease
- Nonalcoholic Fatty Liver Disease (NAFLD)
- MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
- MASLD
- NAFLD
- Metabolic Dysfunction-Associated Steatotic Liver Disease
- NAFLD (Nonalcoholic Fatty Liver Disease)
- NAFLD (Non-alcoholic Fatty Liver Disease)
- NAFLD - Non-Alcoholic Fatty Liver Disease
- NAFLD - Nonalcoholic Fatty Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Pectin
- **OTHER:** Cocoa Powder
- **DIAGNOSTIC_TEST:** Magnetic Resonance Imaging with Contrast

## Key facts

- **NCT ID:** NCT07093346
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-10
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07093346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07093346, "The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07093346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*